Kezar Life Sciences, Inc.KZRNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank67
3Y CAGR-4.3%
5Y CAGR+7.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-4.3%/yr
vs +29.5%/yr prior
5Y CAGR
+7.6%/yr
Recent deceleration
Acceleration
-33.8pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44.71M | -32.0% |
| 2024 | $65.74M | -23.3% |
| 2023 | $85.70M | +68.0% |
| 2022 | $51.01M | +31.0% |
| 2021 | $38.94M | +25.4% |
| 2020 | $31.04M | +10.9% |
| 2019 | $28.00M | +54.4% |
| 2018 | $18.14M | +180.4% |
| 2017 | $6.47M | -12.3% |
| 2016 | $7.37M | - |